Literature DB >> 21784974

Chronic fetal exposure to Ureaplasma parvum suppresses innate immune responses in sheep.

Suhas G Kallapur1, Boris W Kramer, Christine L Knox, Clare A Berry, Jennifer J P Collins, Matthew W Kemp, Ilias Nitsos, Graeme R Polglase, James Robinson, Noah H Hillman, John P Newnham, Claire Chougnet, Alan H Jobe.   

Abstract

The chorioamnionitis associated with preterm delivery is often polymicrobial with ureaplasma being the most common isolate. To evaluate interactions between the different proinflammatory mediators, we hypothesized that ureaplasma exposure would increase fetal responsiveness to LPS. Fetal sheep were given intra-amniotic (IA) injections of media (control) or Ureaplasma parvum serovar 3 either 7 or 70 d before preterm delivery. Another group received an IA injection of Escherichia coli LPS 2 d prior to delivery. To test for interactions, IA U. parvum-exposed animals were challenged with IA LPS and delivered 2 d later. All animals were delivered at 124 ± 1-d gestation (term = 150 d). Compared with the 2-d LPS exposure group, the U. parvum 70 d + LPS group had 1) decreased lung pro- and anti-inflammatory cytokine expression and 2) fewer CD3(+) T lymphocytes, CCL2(+), myeloperoxidase(+), and PU.1(+) cells in the lung. Interestingly, exposure to U. parvum for 7 d did not change responses to a subsequent IA LPS challenge, and exposure to IA U. parvum alone induced mild lung inflammation. Exposure to U. parvum increased pulmonary TGF-β1 expression but did not change mRNA expression of either the receptor TLR4 or some of the downstream mediators in the lung. Monocytes from fetal blood and lung isolated from U. parvum 70 d + LPS but not U. parvum 7 d + LPS animals had decreased in vitro responsiveness to LPS. These results are consistent with the novel finding of downregulation of LPS responses by chronic but not acute fetal exposures to U. parvum. The findings increase our understanding of how chorioamnionitis-exposed preterm infants may respond to lung injury and postnatal nosocomial infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784974      PMCID: PMC3159703          DOI: 10.4049/jimmunol.1100779

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  SOCS-1 participates in negative regulation of LPS responses.

Authors:  Reiko Nakagawa; Tetsuji Naka; Hiroko Tsutsui; Minoru Fujimoto; Akihiro Kimura; Tatsuo Abe; Ekihiro Seki; Shintaro Sato; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira; Koichi Yamanishi; Ichirou Kawase; Kenji Nakanishi; Tadamitsu Kishimoto
Journal:  Immunity       Date:  2002-11       Impact factor: 31.745

2.  SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling.

Authors:  David Wald; Jinzhong Qin; Zhendong Zhao; Youcun Qian; Mayumi Naramura; Liping Tian; Jennifer Towne; John E Sims; George R Stark; Xiaoxia Li
Journal:  Nat Immunol       Date:  2003-08-17       Impact factor: 25.606

3.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

4.  The complete sequence of the mucosal pathogen Ureaplasma urealyticum.

Authors:  J I Glass; E J Lefkowitz; J S Glass; C R Heiner; E Y Chen; G H Cassell
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

5.  Endotoxin-induced lung maturation in preterm lambs is not mediated by cortisol.

Authors:  A H Jobe; J P Newnham; K E Willet; T J Moss; M Gore Ervin; J F Padbury; P Sly; M Ikegami
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

6.  GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1.

Authors:  Y Shibata; P Y Berclaz; Z C Chroneos; M Yoshida; J A Whitsett; B C Trapnell
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

7.  Ureaplasma urealyticum modulates endotoxin-induced cytokine release by human monocytes derived from preterm and term newborns and adults.

Authors:  W M Manimtim; J D Hasday; L Hester; K D Fairchild; J C Lovchik; R M Viscardi
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

8.  Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery.

Authors:  Stefan Gerber; Yvan Vial; Patrick Hohlfeld; Steven S Witkin
Journal:  J Infect Dis       Date:  2003-01-24       Impact factor: 5.226

9.  Biovar diversity of Ureaplasma urealyticum in amniotic fluid: distribution, intrauterine inflammatory response and pregnancy outcomes.

Authors:  Miha Kim; Gilja Kim; Roberto Romero; Soon-Sup Shim; Eui-Chong Kim; Bo Hyun Yoon
Journal:  J Perinat Med       Date:  2003       Impact factor: 1.901

10.  Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.

Authors:  Kimberly Burns; Sophie Janssens; Brian Brissoni; Natalia Olivos; Rudi Beyaert; Jürg Tschopp
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

View more
  36 in total

1.  Intra-amniotic LPS and antenatal betamethasone: inflammation and maturation in preterm lamb lungs.

Authors:  Elke Kuypers; Jennifer J P Collins; Boris W Kramer; Gaston Ofman; Ilias Nitsos; J Jane Pillow; Graeme R Polglase; Matthew W Kemp; John P Newnham; Antonio W D Gavilanes; Relana Nowacki; Machiko Ikegami; Alan H Jobe; Suhas G Kallapur
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-09       Impact factor: 5.464

Review 2.  The Human Ureaplasma Species as Causative Agents of Chorioamnionitis.

Authors:  Emma L Sweeney; Samantha J Dando; Suhas G Kallapur; Christine L Knox
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

3.  A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes.

Authors:  Roberto Romero; Jezid Miranda; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Francesca Gotsch; Zhong Dong; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Chong Jai Kim; Steven J Korzeniewski; Lami Yeo
Journal:  Am J Reprod Immunol       Date:  2014-01-13       Impact factor: 3.886

Review 4.  Fetal immune response to chorioamnionitis.

Authors:  Suhas G Kallapur; Pietro Presicce; Cesar M Rueda; Alan H Jobe; Claire A Chougnet
Journal:  Semin Reprod Med       Date:  2014-01-03       Impact factor: 1.303

5.  Modulation of lipopolysaccharide-induced chorioamnionitis by Ureaplasma parvum in sheep.

Authors:  Candice C Snyder; Katherine B Wolfe; Tate Gisslen; Christine L Knox; Matthew W Kemp; Boris W Kramer; John P Newnham; Alan H Jobe; Suhas G Kallapur
Journal:  Am J Obstet Gynecol       Date:  2013-02-11       Impact factor: 8.661

Review 6.  Ureaplasma and BPD.

Authors:  Suhas G Kallapur; Boris W Kramer; Alan H Jobe
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

7.  Invariant NKT Cell Activation Induces Late Preterm Birth That Is Attenuated by Rosiglitazone.

Authors:  Derek St Louis; Roberto Romero; Olesya Plazyo; Marcia Arenas-Hernandez; Bogdan Panaitescu; Yi Xu; Tatjana Milovic; Zhonghui Xu; Gaurav Bhatti; Qing-Sheng Mi; Sascha Drewlo; Adi L Tarca; Sonia S Hassan; Nardhy Gomez-Lopez
Journal:  J Immunol       Date:  2016-01-06       Impact factor: 5.422

Review 8.  Role of Ureaplasma Respiratory Tract Colonization in Bronchopulmonary Dysplasia Pathogenesis: Current Concepts and Update.

Authors:  Rose Marie Viscardi; Suhas G Kallapur
Journal:  Clin Perinatol       Date:  2015-10-09       Impact factor: 3.430

Review 9.  Ureaplasma species: role in neonatal morbidities and outcomes.

Authors:  Rose Marie Viscardi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2013-08-19       Impact factor: 5.747

Review 10.  An Immunological Perspective on Neonatal Sepsis.

Authors:  Bernard Kan; Hamid Reza Razzaghian; Pascal M Lavoie
Journal:  Trends Mol Med       Date:  2016-03-15       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.